1324286 Alberta

1324286 Alberta Limited is a private Canadian investment and holding company that serves as a primary vehicle for the FMRC Family Trust, associated with the Bellini family, including Dr. Francesco Bellini and Roberto Bellini. The company has historically held significant ownership stakes in prominent biotechnology firms, most notably BELLUS Health Inc. (formerly Neurochem) and Thallion Pharmaceuticals. Through its holdings, 1324286 Alberta has played a key role in the governance and strategic direction of its portfolio companies, which focus on developing therapeutics for chronic cough and infectious diseases. The company was a major shareholder in BELLUS Health until its acquisition by GSK in 2023 for approximately $2 billion. It has also been involved in notable legal proceedings in Canada regarding the valuation of biotechnology assets for tax purposes.